Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Role of Oxidative Stress in Antenatal Synthetic Glucocorticoid Therapy

EF 2016-17

Résumé
Women at risk of preterm delivery are treated with synthetic versions of the stress hormone cortisol (sGC) to stimulate maturation of the fetal lungs. However, this life-saving therapy has been associated with adverse endocrine and behavioural outcomes in the offspring. Oxidative damage likely represents one mechanism through which sGC acts on the developing brain leading to long-term sequelae. Potentially damaging reactive oxygen species (ROS) are balanced by antioxidants in cells. Oxidative damage occurs when this balance is disturbed by an over-abundance of ROS, and is associated with increased cellular and DNA damage. Previous research has shown that patterns of gene expression within the hippocampus of the brain are altered following sGC therapy, via epigenetic changes such as modified DNA methylation. This study aims to show that oxidative damage is a mechanism though which prenatal exposure to synthetic glucocorticoids leads to epigenetic changes in the fetal hippocampus, and that this oxidative damage can be prevented with antioxidants. Guinea pigs will be used as a gestational model to investigate the effects of sGC on the developing fetus. Maternal guinea pigs will be treated with either antioxidants or saline throughout their pregnancy and will receive either sGC or saline injections during late gestation. The animals will be sacrificed before term, and fetal brain tissue will be analyzed for changes in biomarkers of oxidative damage in response to sGC and antioxidants. This study is clinically relevant as up to 10% of births are at risk of preterm delivery and will be getting sGC therapy. It is critical to understand the long-term consequences of this therapy and the mechanisms that underlie them.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
368978
Name
Sarkar Susmita
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of Oxidative Stress in Antenatal Synthetic Glucocorticoid Therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antioxidant Therapy; Neurodevelopment; Oxidative Damage; Preterm Birth; Synthetic Glucorticoid Therapy
Abstract
Women at risk of preterm delivery are treated with synthetic versions of the stress hormone cortisol (sGC) to stimulate maturation of the fetal lungs. However, this life-saving therapy has been associated with adverse endocrine and behavioural outcomes in the offspring. Oxidative damage likely represents one mechanism through which sGC acts on the developing brain leading to long-term sequelae. Potentially damaging reactive oxygen species (ROS) are balanced by antioxidants in cells. Oxidative damage occurs when this balance is disturbed by an over-abundance of ROS, and is associated with increased cellular and DNA damage. Previous research has shown that patterns of gene expression within the hippocampus of the brain are altered following sGC therapy, via epigenetic changes such as modified DNA methylation. This study aims to show that oxidative damage is a mechanism though which prenatal exposure to synthetic glucocorticoids leads to epigenetic changes in the fetal hippocampus, and that this oxidative damage can be prevented with antioxidants. Guinea pigs will be used as a gestational model to investigate the effects of sGC on the developing fetus. Maternal guinea pigs will be treated with either antioxidants or saline throughout their pregnancy and will receive either sGC or saline injections during late gestation. The animals will be sacrificed before term, and fetal brain tissue will be analyzed for changes in biomarkers of oxidative damage in response to sGC and antioxidants. This study is clinically relevant as up to 10% of births are at risk of preterm delivery and will be getting sGC therapy. It is critical to understand the long-term consequences of this therapy and the mechanisms that underlie them.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sarkar, Susmita
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~